SUBOXONE 2 MG0.5 MG Израел - Енглески - Ministry of Health

suboxone 2 mg0.5 mg

naomi shaco-ezra ltd - buprenorphine hydrochloride; naloxone hydrochloride dihydrate - tablets sublingual - buprenorphine hydrochloride 2.16 mg; naloxone hydrochloride dihydrate 0.61 mg - buprenorphine - buprenorphine - substitution treatment for opioid drug dependence, within a framework of medical, social and psychological treatment. the intention of the naloxone component is to deter intravenous misuse.treatment is intended for use in adults and adolescents over 15 years of age who have agreed to be treated for addiction.

SUBOXONE 8 MG  2 MG Израел - Енглески - Ministry of Health

suboxone 8 mg 2 mg

naomi shaco-ezra ltd - buprenorphine hydrochloride; naloxone hydrochloride dihydrate - tablets sublingual - buprenorphine hydrochloride 8.64 mg; naloxone hydrochloride dihydrate 2.44 mg - buprenorphine - buprenorphine - substitution treatment for opioid drug dependence, within a framework of medical, social and psychological treatment. the intention of the naloxone component is to deter intravenous misuse.treatment is intended for use in adults and adolescents over 15 years of age who have agreed to be treated for addiction

Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) Европска Унија - Енглески - EMA (European Medicines Agency)

adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)

glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human, immunization, disease outbreaks - vaccines, - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official guidance.,

Ecokinase Европска Унија - Енглески - EMA (European Medicines Agency)

ecokinase

roche registration ltd. - reteplase - myocardial infarction - antithrombotic agents - thrombolytic therapy of acute myocardial infarction

Bovilis BTV8 Европска Унија - Енглески - EMA (European Medicines Agency)

bovilis btv8

intervet international bv - bluetongue virus vaccine, serotype 8 (inactivated) - inactivated viral vaccines, bluetongue virus, sheep - sheep; cattle - cattle to stimulate active immunity in sheep from 6 weeks of age against bluetongue virus serotype 8 to reduce viraemia sheep to stimulate active immunity in sheep from 1 month of age against bluetongue virus serotype 8 to prevent viraemia,

Zulvac 1 Bovis Европска Унија - Енглески - EMA (European Medicines Agency)

zulvac 1 bovis

zoetis belgium sa - inactivated bluetongue virus, serotype 1 - immunologicals - cattle - active immunisation of cattle from 2½ months of age for the prevention of viraemia caused by bluetongue virus, serotype 1.onset of immunity: 15 days after completion of the primary vaccination course.duration of immunity: 12 months.